Skip to main content

Table 2 Hormonal and metabolic features of adolescents with and without PCOS

From: Metabolic abnormalities in adolescents with polycystic ovary syndrome in south china

  

PCOS

 

Control

Rotterdam criteria

NIH criteria

FSH(IU/L)

5.3(4.4-6.6)

5.6(4.5-6.9)

5.6(4.5-6.9)

LH(IU/L)

5.1(3.6-7.5)

11.0(5.9-16.1) **

10.3(6.3-16.2) **

TT(nmol/L)

1.7(1.5-2.4)

2.5(2.0-3.2) **

2.8(2.3-3.3) **

FT(pg/ml)

2.9(2.1-3.5)

4.6(2.6-7.3) **

5.1(2.9-8.1) **

Fasting glucose(mmol/L)

4.7(4.5-4.8)

4.8(4.5-5.0)

4.8(4.5-5.1)

2-h glucose(mmol/L)

5.6(5.0-6.3)

6.3(5.1-7.1) *

6.3(5.3-7.1) **

Fasting insulin(μU/ml)

5.7(4.4-8.3)

8.8(5.7-13.2) **

9.0(5.9-13.2) **

2-h insulin(μU/ml)

48.1(35.5-82.4)

72.7(46.6-131.9) *

76.7(51.0-139.) **

HOMA-IR

1.2(0.9-1.8)

1.9(1.2-2.9) **

1.9(1.4-2.9) **

CHOL(mmol/L)

4.2(3.7-4.7)

4.5(4.1-5.1)

4.5(4.1-5.1)

TG(mmol/L)

0.9(0.7-1.2)

1.0(0.8-1.3)

1.0(0.7-1.3)

HDL(mmol/L)

1.6(1.4-1.7)

1.6(1.4-1.9)

1.5(1.3-1.9)

LDL(mmol/L)

2.6(2.1-2.9)

2.5(2.1-3.1)

2.5(2.1-3.2)

  1. Variables were expressed as median with (interquartile range).
  2. FSH: follicle stimulating hormone; LH: luteinizing hormone; TT: total testosterone; FT: free testosterone; HOMA-IR: Homeostasis Model Assessment of Insulin Resistance; CHOL: total cholesterol; TG: triglyceride; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol.
  3. *P < 0.05, **P < 0.01 vs. control.